Logo Universitätsmedizin Göttingen
Nephrologie > Forschung > Publikationen

Publikationen

Klinik für Nephrologie und Rheumatologie

2020

Journalbeiträge

  1. Becker LM, O'Connell JT, Vo AP, Cain MP, Tampe D, Bizarro L, Sugimoto H, McGow AK, Asara JM, Lovisa S, McAndrews KM, Zielinski R, Lorenzi PL, Zeisberg M, Raza S, LeBleu VS, Kalluri R (2020) Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer. CELL REP 31(9): 107701, doi: 10.1016/j.celrep.2020.107701
  2. Boeckhaus J, Strenzke N, Storz C, Gross O, On Behalf Of The Gpn Study Group, Early Pro-Tect Alport Investigators (2020) Characterization of Sensorineural Hearing Loss in Children with Alport Syndrome. LIFE-BASEL 10(12): -, doi: 10.3390/life10120360
  3. Braun F, Lütgehetmann M, Pfefferle S, Wong MN, Carsten A, Lindenmeyer MT, Nörz D, Heinrich F, Meißner K, Wichmann D, Kluge S, Gross O, Pueschel K, Schröder AS, Edler C, Aepfelbacher M, Puelles VG, Huber TB (2020) SARS-CoV-2 renal tropism associates with acute kidney injury. LANCET 396(10251): 597-598, doi: 10.1016/S0140-6736(20)31759-1
  4. Burgmaier K, Ariceta G, Bald M, Buescher AK, Burgmaier M, Erger F, Gessner M, Gokce I, König J, Kowalewska C, Massella L, Mastrangelo A, Mekahli D, Pape L, Patzer L, Potemkina A, Schalk G, Schild R, Shroff R, Szczepanska M, Taranta-Janusz K, Tkaczyk M, Weber LT, Wühl E, Wurm D, Wygoda S, Zagozdzon I, Dötsch J, Oh J, Schaefer F, Liebau MC, ARegPKD consortium (2020) Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD). SCI REP-UK 10(1): 16025, doi: 10.1038/s41598-020-71956-1
  5. Dihazi GH, Eltoweissy M, Jahn O, Tampe B, Zeisberg M, Wülfrath HS, Müller GA, Dihazi H (2020) The Secretome Analysis of Activated Human Renal Fibroblasts Revealed Beneficial Effect of the Modulation of the Secreted Peptidyl-Prolyl Cis-Trans Isomerase A in Kidney Fibrosis. CELLS-BASEL 9(7): 1-23, doi: 10.3390/cells9071724
  6. Graef ER, Liew JW, Putman MS, Simard JF, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig MF, Korsten P, Proulx L, Richards DP, Robinson PC, Sattui SE, Ugarte-Gil MF, Young KJ, Kim AH, Sparks JA, COVID-19 Global Rheumatology Alliance (2020) Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. ANN RHEUM DIS 79(6): 734-736, doi: 10.1136/annrheumdis-2020-217480
  7. Gross O (2020) [COVID-19 and the kidneys-Clinical aspects]. Nephrologe -: 1-6, doi: 10.1007/s11560-020-00470-2
  8. Gross O (2020) Vererbbare Nierenerkrankungen (Zystennieren, Alport). Library connect : newsletter ; partnering with the library community / publ. by Elsevier Inc. Elsevier Essentials Nephrologie 1. Aufl. Kap. 8(ISBN 978-3437216916): 4 Seiten
  9. Gross O, Moerer O, Weber M, Huber TB, Scheithauer S (2020) COVID-19-associated nephritis: early warning for disease severity and complications? LANCET 395(10236): e87-e88, doi: 10.1016/S0140-6736(20)31041-2
  10. Gross O, Tönshoff B, Weber LT, Pape L, Latta K, Fehrenbach H, Lange-Sperandio B, Zappel H, Hoyer P, Staude H, König S, John U, Gellermann J, Hoppe B, Galiano M, Hoecker B, Ehren R, Lerch C, Kashtan CE, Harden M, Boeckhaus J, Friede T, German Pediatric Nephrology (GPN) Study Group and EARLY PRO-TECT Alport Investigators (2020) A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome. KIDNEY INT 97(6): 1275-1286, doi: 10.1016/j.kint.2019.12.015
  11. Hakroush S, Franz J, Larsen J, Korsten P, Winkler MS, Tampe B (2020) Repeated false-negative tests delayed diagnosis of COVID-19 in a case with granulomatosis with polyangiitis under maintenance therapy with rituximab and concomitant influenza pneumonia. ANN RHEUM DIS -: -, doi: 10.1136/annrheumdis-2020-218491
  12. Hakroush S, Tampe D, Korsten P, Stroebel P, Zeisberg M, Tampe B (2020) Histopathological findings predict renal recovery in severe ANCA-associated vasculitis requiring intensive care treatment. FRONT MED-LAUSANNE 2020.622028: -, doi: 10.3389
  13. Heusser K, Thöne A, Lipp A, Menne J, Beige J, Reuter H, Hoffmann F, Halbach M, Eckert S, Wallbach M, Koziolek M, Haarmann H, Joyner MJ, Paton JFR, Diedrich A, Haller H, Jordan J, Tank J (2020) Efficacy of Electrical Baroreflex Activation Is Independent of Peripheral Chemoreceptor Modulation. HYPERTENSION 75(1): 257-264, doi: 10.1161/HYPERTENSIONAHA.119.13925
  14. Hofmann-Winkler H, Moerer O, Alt-Epping S, Bräuer A, Büttner B, Müller M, Fricke T, Grundmann J, Harnisch LO, Heise D, Kernchen A, Pressler M, Stephani C, Tampe B, Kaul A, Gärtner S, Kramer S, Pöhlmann S, Winkler MS (2020) Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation. Crit Care Explor 2(11): e0284, doi: 10.1097/CCE.0000000000000284
  15. Juche A, Siegert E, Mueller-Ladner U, Riemekasten G, Günther C, Kötter I, Henes J, Blank N, Voll RE, Ehrchen J, Schmalzing M, Susok L, Schmeiser T, Sunderkoetter C, Distler J, Worm M, Kreuter A, Horváth ON, Schön MP, Korsten P, Zeidler G, Pfeiffer C, Krieg T, Hunzelmann N, Moinzadeh P (2020) [Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]. Z RHEUMATOL 79(10): 1057-1066, doi: 10.1007/s00393-019-00743-9
  16. Kashtan CE, Gross O (2020) Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020. PEDIATR NEPHROL -: -, doi: 10.1007/s00467-020-04819-6
  17. Kim AHJ, Sparks JA, Liew JW, Putman MS, Berenbaum F, Duarte-García A, Graef ER, Korsten P, Sattui SE, Sirotich E, Ugarte-Gil MF, Webb K, Grainger R (2020) A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. ANN INTERN MED 172(12): 819-821, doi: 10.7326/M20-1223
  18. Korendovych V, Fleischhammer J, Tampe B, Nikiphorou E, Vasko R, Müller GA, Korsten P (2020) Severely destructive unilateral wrist arthritis as a rare variant of rheumatoid arthritis: analysis of clinical and imaging features. CLIN EXP RHEUMATOL -: -
  19. Korsten P (2020) A "groovy" diagnosis: Eosinophilic fasciitis. Clin Case Rep 8(12): 3545-3546, doi: 10.1002/ccr3.3128
  20. Korsten P, Schmidt J, Larsen J, Seitz CS (2020) Mechanic's hands in a patient with isolated anti-Ro52 antibodies: antisynthetase syndrome without antisynthetase antibodies. J DTSCH DERMATOL GES 18(2): 147-148, doi: 10.1111/ddg.13985
  21. Korsten P, Wallbach M, Binder C (2020) Type 2A von Willebrand disease and systemic sclerosis: Vonicog alfa reduced gastrointestinal bleeding. Res Pract Thromb Haemost 4(7): 1230-1234, doi: 10.1002/rth2.12426
  22. Koziolek M, Mueller GA, Dihazi GH, Jung K, Altubar C, Wallbach M, Markovic I, Raddatz D, Jahn O, Karaköse H, Lenz C, Urlaub H, Dihazi A, El Meziane A, Dihazi H (2020) Urine E-cadherin: A Marker for Early Detection of Kidney Injury in Diabetic Patients. J CLIN MED 9(3): 1-21, doi: 10.3390/jcm9030639
  23. Lauermann P, Storch M, Weig M, Tampe B, Winkler M, Hoerauf H, Feltgen N, Hakroush S (2020) There is no intraocular affection on a SARS-CoV-2 - Infected ocular surface. Am J Ophthalmol Case Rep 20: 100884, doi: 10.1016/j.ajoc.2020.100884
  24. Lipphardt M, Dihazi H, Maas JH, Schäfer AK, Amlaz SI, Ratliff BB, Koziolek MJ, Wallbach M (2020) Syndecan-4 as a Marker of Endothelial Dysfunction in Patients with Resistant Hypertension. J CLIN MED 9(9): 1-15, doi: 10.3390/jcm9093051
  25. Lipphardt M, Song JW, Goligorsky MS (2020) Sirtuin 1 and endothelial glycocalyx. PFLUG ARCH EUR J PHY 472(8): 991-1002, doi: 10.1007/s00424-020-02407-z
  26. Lipphardt M, Wallbach M, Koziolek MJ (2020) Plasma Exchange or Immunoadsorption in Demyelinating Diseases: A Meta-Analysis. J CLIN MED 9(5): 1-19, doi: 10.3390/jcm9051597
  27. Lovisa S, Fletcher-Sananikone E, Sugimoto H, Hensel J, Lahiri S, Hertig A, Taduri G, Lawson E, Dewar R, Revuelta I, Kato N, Wu CJ, Bassett RL, Putluri N, Zeisberg M, Zeisberg EM, LeBleu VS, Kalluri R (2020) Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis. SCI SIGNAL 13(635): 1-17, doi: 10.1126/scisignal.aaz2597
  28. Najm A, Alunno A, Sivera F, Ramiro S, Haines C, Working Group on Training in Rheumatology across Europe (2020) Strategies for the assessment of competences during rheumatology training across Europe: results of a qualitative study. RMD Open 6(2): -, doi: 10.1136/rmdopen-2020-001183
  29. Patschan D, Schwarze K, Tampe B, Becker JU, Hakroush S, Ritter O, Patschan S, Müller GA (2020) Constitutive Atg5 overexpression in mouse bone marrow endothelial progenitor cells improves experimental acute kidney injury. BMC NEPHROL 21(1): 503, doi: 10.1186/s12882-020-02149-1
  30. Plüß M, Chehab G, Korsten P (2020) Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey. ANN RHEUM DIS na: 1-2, doi: 10.1136/annrheumdis-2020-217967
  31. Plüß M, Tampe B, Hakroush S, Niebusch N, Arnaud L, Korsten P (2020) Therapeutic Implications of Renal Biopsies to Detect Proliferative Lupus Nephritis in Patients With Low-Grade Proteinuria. KIDNEY INT REP 5(11): 2120-2121, doi: 10.1016/j.ekir.2020.08.023
  32. Plüß M, Tampe B, Niebusch N, Zeisberg M, Müller GA, Korsten P (2020) Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus. FRONT MED-LAUSANNE 7: 222, doi: 10.3389/fmed.2020.00222
  33. Puelles VG, Lütgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, Braun F, Lu S, Pfefferle S, Schröder AS, Edler C, Gross O, Glatzel M, Wichmann D, Wiech T, Kluge S, Pueschel K, Aepfelbacher M, Huber TB (2020) Multiorgan and Renal Tropism of SARS-CoV-2. NEW ENGL J MED 383(6): 590-592, doi: 10.1056/NEJMc2011400
  34. Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A, COVID-19 Global Rheumatology Alliance (2020) Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Arthritis Rheum-us 73: 36-47, doi: 10.1002/art.41469
  35. Rauen T, Wied S, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Budde K, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J, STOP-IgAN Investigators (2020) After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. KIDNEY INT 98(4): 1044-1052, doi: 10.1016/j.kint.2020.04.046
  36. Rheault MN, Savige J, Randles MJ, Weinstock A, Stepney M, Turner AN, Parziale G, Gross O, Flinter FA, Miner JH, Lagas S, Gear S, Lennon R (2020) The importance of clinician, patient and researcher collaborations in Alport syndrome. PEDIATR NEPHROL 35(5): 733-742, doi: 10.1007/s00467-019-04241-7
  37. Rudnicki M, Siwy J, Wendt R, Lipphardt M, Koziolek MJ, Maixnerova D, Peters B, Kerschbaum J, Leierer J, Neprasova M, Banasik M, Sanz AB, Perez-Gomez MV, Ortiz A, Stegmayr B, Tesar V, Mischak H, Beige J, Reich HN, PERSTIGAN working group (2020) Urine proteomics for prediction of disease progression in patients with IgA nephropathy. NEPHROL DIAL TRANSPL Online ahead of print.: 1-11, doi: 10.1093/ndt/gfaa307
  38. Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA (2020) Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. EXPERT REV CLIN IMMU 16(7): 659-666, doi: 10.1080/1744666X.2020.1792778
  39. Schmalz G, Patschan D, Schmickler J, Bethke N, Scherzinger E, Müller GA, Ziebolz D, Patschan S (2020) Oral health-related quality of life in different rheumatic diseases. ORAL DIS 26(8): 1783-1792, doi: 10.1111/odi.13464
  40. Schubert N, Schill T, Plüß M, Korsten P (2020) Flare or foe? - Mycobacterium marinum infection mimicking rheumatoid arthritis tenosynovitis: case report and literature review. BMC Rheumatol 4: 11, doi: 10.1186/s41927-020-0114-3
  41. Send T, Korsten P, Bertlich M, Braunwarth C, Bootz F, Skowasch D, Jakob M (2020) Clinical features of sarcoidosis patients presenting with head and neck manifestations - a two-center retrospective study and proposal of a diagnostic algorithm for the otorhinolaryngologist. ACTA OTO-LARYNGOL 140(2): 144-148, doi: 10.1080/00016489.2019.1698767
  42. Sweiss NJ, Korsten P, Syed HJ, Syed A, Baughman RP, Yee AMF, Culver DA, Sosenko T, Azuma A, Bonella F, Costabel U, Drake WP, Drent M, Lower EE, Israel-Biet D, Mostard RLM, Nunes H, Rottoli P, Spagnolo P, Wells AU, Wuyts WA, Judson MA (2020) When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic. CHEST 158(3): 892-895, doi: 10.1016/j.chest.2020.04.033
  43. Taylan C, Driemeyer J, Schmitt CP, Pape L, Büscher R, Galiano M, König J, Schürfeld C, Spitthöver R, Versen A, Koziolek M, Marsen TA, Stein H, Schaefer JR, Heibges A, Klingel R, Oh J, Weber LT, Klaus G (2020) Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis. AM J CARDIOL 136: 38-48, doi: 10.1016/j.amjcard.2020.09.015
  44. von Haehling S, Arzt M, Doehner W, Edelmann F, Evertz R, Ebner N, Herrmann-Lingen C, Garfias Macedo T, Koziolek M, Noutsias M, Schulze PC, Wachter R, Hasenfuß G, Laufs U (2020) Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials. EUR J HEART FAIL Online ahead of print.: 1-22, doi: 10.1002/ejhf.1838
  45. Wallbach M, Born E, Kämpfer D, Lüders S, Müller GA, Wachter R, Koziolek MJ (2020) Long-term effects of baroreflex activation therapy: 2-year follow-up data of the BAT Neo system. CLIN RES CARDIOL 109(4): 513-522, doi: 10.1007/s00392-019-01536-5
  46. Weinstock BA, Feldman DL, Fornoni A, Gross O, Kashtan CE, Lagas S, Lennon R, Miner JH, Rheault MN, Simon JF, Workshop Participants (2020) Clinical trial recommendations for potential Alport syndrome therapies. KIDNEY INT 97(6): 1109-1116, doi: 10.1016/j.kint.2020.02.029
  47. Wilhelmi T, Xu X, Tan X, Hulshoff MS, Maamari S, Sossalla S, Zeisberg M, Zeisberg EM (2020) Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1. THERANOSTICS 10(9): 3905-3924, doi: 10.7150/thno.38640
  48. Winkler MS, Korsten P, Binder C, Tampe B (2020) Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'. ANN RHEUM DIS na (online): 1-2, doi: 10.1136/annrheumdis-2020-218836
  49. Xu X, Hulshoff MS, Tan X, Zeisberg M, Zeisberg EM (2020) CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications. INT J MOL SCI 21(9): 1-19, doi: 10.3390/ijms21093038


Medizinische Dissertationen

  1. Künanz J, Dr. med. (2020) Der langfristige Effekt einer RAAS-Blockade auf den Krankheitsverlauf bei heterozygoten Mutationsträgern des Alport-Syndroms - Eine prospektive Vier-Jahres-Auswertung des Europäischen Alport-Registers. Dissertation Universität Göttingen.
  2. Sugiarto NR, Dr. med. (2020) Die Rolle der endothelialen Progenitorzellen und Gefäßsteifigkeit bei Patienten mit Psoriasis-Arthritis. Dissertation Universität Göttingen.
  3. Valk JJ, Dr. med. (2020) Komplementinhibition mittels Eculizumab verstärkt den nephroprotektiven Effekt von ACE-Inhibitoren in einem COL4A3-Knockout-Mausmodell für das Alport-Syndrom. Dissertation Universität Göttingen.

2019

  1. Delistefani F, Wallbach M, Müller GA, Koziolek MJ, Grupp C (2019) Risk factors for catheter-related infections in patients receiving permanent dialysis catheter. BMC NEPHROL 20(1): 199, doi: 10.1186/s12882-019-1392-0
  2. Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R (2019) Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment. Front Med (Lausanne) 6: 238, doi: 10.3389/fmed.2019.00238
  3. Frese J, Kettwig M, Zappel H, Hofer J, Gröne HJ, Nagel M, Sunder-Plassmann G, Kain R, Neuweiler J, Gross O (2019) Kidney Injury by Variants in the COL4A5 Gene Aggravated by Polymorphisms in Slit Diaphragm Genes Causes Focal Segmental Glomerulosclerosis. INT J MOL SCI 20(3): -, doi: 10.3390/ijms20030519
  4. Gross O, Hoefele J (2019) Alport-Syndrom. medgen-Themenschwerpunkt: Genetische Aspekte der Nierenerkrankungen. Med Genet-berlin 30(4): 429-437
  5. Gross O, Rascher W (2019) Nephroprotektive Therapie am Beispiel des Alport Syndroms.Themenheft Nephrologie. MONATSSCHR KINDERH 167 (6): 522-529, doi: 10.1007/s00112-018-0641-9
  6. Grupp C, Troche-Polzien I, Stock J, Bramlage C, Müller GA, Koziolek M (2019) Thrombophilic risk factors in hemodialysis: Association with early vascular access occlusion and patient survival in long-term follow-up. PLOS ONE 14(9): e0222102, doi: 10.1371/journal.pone.0222102
  7. Hoffmann JC, Patschan D, Dihazi H, Müller C, Schwarze K, Henze E, Ritter O, Müller GA, Patschan S (2019) Cytokine profiling in anti neutrophil cytoplasmic antibody-associated vasculitis: a cross-sectional cohort study. RHEUMATOL INT 39(11): 1907-1917, doi: 10.1007/s00296-019-04364-y
  8. Korsten P (2019) Distal extremity metastases from prostate cancer in a patient with rheumatoid arthritis. Rheumatol Adv Pract 3(2): rkz040, doi: 10.1093/rap/rkz040
  9. Korsten P, Müller GA, Rademacher JG, Zeisberg M, Tampe B (2019) Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments. Front Med (Lausanne) 6: 208, doi: 10.3389/fmed.2019.00208
  10. Korsten P, Seitz CS, Sahlmann CO, Schmidt J (2019) Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis. RHEUMATOLOGY 58(11): 2071-2073, doi: 10.1093/rheumatology/kez313
  11. Lipphardt M, Dihazi H, Jeon NL, Dadafarin S, Ratliff BB, Rowe DW, Müller GA, Goligorsky MS (2019) Dickkopf-3 in aberrant endothelial secretome triggers renal fibroblast activation and endothelial-mesenchymal transition. NEPHROL DIAL TRANSPL 34(1): 49-62, doi: 10.1093/ndt/gfy100
  12. Lipphardt M, Koziolek MJ, Lehnig LY, Schäfer AK, Müller GA, Lüders S, Wallbach M (2019) Effect of baroreflex activation therapy on renal sodium excretion in patients with resistant hypertension. CLIN RES CARDIOL 108(11): 1287-1296, doi: 10.1007/s00392-019-01464-4
  13. Lipphardt M, Mühlhausen J, Kitze B, Heigl F, Mauch E, Helms HJ, Müller GA, Koziolek MJ (2019) Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica. J CLIN APHERESIS 34(4): 381-391, doi: 10.1002/jca.21686
  14. Macheroux EP, Braunisch MC, Pucci Pegler S, Satanovskij R, Riedhammer KM, Günthner R, Gross O, Nagel M, Renders L, Hoefele J (2019) The Hypomorphic Variant p.(Gly624Asp) in COL4A5 as a Possible Cause for an Unexpected Severe Phenotype in a Family With X-Linked Alport Syndrome. FRONT PEDIATR 7: 485, doi: 10.3389/fped.2019.00485
  15. Patschan D, Schwarze K, Henze E, Hoffmann JC, Patschan S, Ritter O, Muller GA (2019) Acute Kidney Injury-Associated Systemic Inflammation Is Aggravated in Insulin-Dependent Diabetes Mellitus. J Clin Med Res 11(10): 720-723, doi: 10.14740/jocmr3852
  16. Patschan S, Vogt M, Bakhtiari D, Bramlage CP, Henze E, Muller GA, Krause A, Patschan D (2019) Humoral and Cellular Patterns of Early Endothelial Progenitor Cells in Relation to the Cardiovascular Risk in Axial Spondylarthritis. J Clin Med Res 11(6): 391-400, doi: 10.14740/jocmr3441w
  17. Rademacher JG, Wincup C, Tampe B, Korsten P (2019) Combination therapy with bosentan and sildenafil for refractory digital ulcers and Raynaud's phenomenon in a 30-year-old woman with systemic sclerosis: case report and literature review. J Sclerod Relat Dis -: doi:10.1177/2397198319876738
  18. Rheault MN, Savige J, Randles MJ, Weinstock A, Stepney M, Turner AN, Parziale G, Gross O, Flinter FA, Miner JH, Lagas S, Gear S, Lennon R (2019) The importance of clinician, patient and researcher collaborations in Alport syndrome. PEDIATR NEPHROL -: -, doi: 10.1007/s00467-019-04241-7
  19. Schrempf LE, Tampe B, Korsten P (2019) [A 82-Year-Old Female Patient with Rheumatoid Arthritis and Neck Pain]. DEUT MED WOCHENSCHR 144(5): 305-306, doi: 10.1055/a-0818-9623
  20. van Roeyen CRC, Martin IV, Drescher A, Schuett KA, Hermert D, Raffetseder U, Otten S, Buhl EM, Braun GS, Kuppe C, Liehn E, Boor P, Weiskirchen R, Eriksson U, Gross O, Eitner F, Floege J, Ostendorf T (2019) Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension. KIDNEY INT 95(5): 1103-1119, doi: 10.1016/j.kint.2018.11.031
  21. Vogelgsang J, Heßmann P, Wolff-Menzler C, Gyßer S, Müller GA, Wiltfang J (2019) Prevalence of affective disorders and dementia in inflammatory polyarthropathies. EUR ARCH PSY CLIN N -: -, doi: 10.1007/s00406-019-01015-y
  22. Wallbach M, Tampe B, Dihazi H, Koziolek MJ (2019) [Acute kidney injury: from creatinine to KIM-1?]. INTERNIST 60(6): 578-586, doi: 10.1007/s00108-019-0602-y
  23. Wallbach M, Lach N, Stock J, Hiller H, Mavropoulou E, Chavanon ML, Neurath H, Blaschke S, Lowin E, Herrmann-Lingen C, Müller GA, Koziolek MJ (2019) Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department. J CLIN HYPERTENS 21(1): 55-63, doi: 10.1111/jch.13448

2018 bis 2016

2018

  1. Bielecka-Dabrowa A, Godoy B, Schefold JC, Koziolek M, Banach M, von Haehling S (2018) Decompensated Heart Failure and Renal Failure: What Is the Current Evidence? Curr Heart Fail Rep x: x, doi: 10.1007/s11897-018-0397-5
  2. Dere E, Ronnenberg A, Tampe B, Arinrad S, Schmidt M, Zeisberg E, Ehrenreich H (2018) Cognitive, emotional and social phenotyping of mice in an observer-independent setting. NEUROBIOL LEARN MEM 150: 136-150, doi: 10.1016/j.nlm.2018.02.023
  3. Dihazi H, Asif AR, Beißbarth T, Bohrer R, Feussner K, Feussner I, Jahn O, Lenz C, Majcherczyk A, Schmidt B, Schmitt K, Urlaub H, Valerius O (2018) Integrative omics - from data to biology. EXPERT REV PROTEOMIC 15(6): 463-466, doi: 10.1080/14789450.2018.1476143
  4. Gross O (2018) Klinik und Therapie des Alport Syndroms. Tägl Prax 60/1: 38-46
  5. Gross O, Bramlage C (2018) [Nephrology for urologists]. UROLOGE 57(7): 855-864, doi: 10.1007/s00120-018-0691-6
  6. Grupp C, Koziolek MJ, Wallbach M, Hoxhold K, Müller GA, Bramlage C (2018) Difference between renal and splenic resistive index as a novel criterion in Doppler evaluation of renal artery stenosis. J CLIN HYPERTENS 20(3): 582-588, doi: 10.1111/jch.13212
  7. Životić M, Tampe B, Müller G, Müller C, Lipkovski A, Xu X, Nyamsuren G, Zeisberg M, Marković-Lipkovski J (2018) Modulation of NCAM/FGFR1 signaling suppresses EMT program in human proximal tubular epithelial cells. PLOS ONE 13(11): e0206786, doi: 10.1371/journal.pone.0206786
  8. Kashtan CE, Ding J, Garosi G, Heidet L, Massella L, Nakanishi K, Nozu K, Renieri A, Rheault M, Wang F, Gross O (2018) Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group. KIDNEY INT 93(5): 1045-1051, doi: 10.1016/j.kint.2017.12.018
  9. Korsten P, Mavropoulou E, Wienbeck S, Ellenberger D, Patschan D, Zeisberg M, Vasko R, Tampe B, Müller GA (2018) The "rapid atrial swirl sign" for assessing central venous catheters: Performance by medical residents after limited training. PLOS ONE 13(7): e0199345, doi: 10.1371/journal.pone.0199345
  10. Korsten P, Tampe B, Konig MF, Nikiphorou E (2018) Sarcoidosis and autoimmune diseases: differences, similarities and overlaps. CURR OPIN PULM MED 24(5): 504-512, doi: 10.1097/MCP.0000000000000500
  11. Krause A, Aries PM, Berger S, Fiehn C, Kellner H, Lorenz HM, Meier L, Müller GA, Müller-Ladner U, Schwarting A, Tony HP, Peters MA, Wendler J (2018) Rituximab in routine care of severe active rheumatoid arthritis: A prospective, non-interventional study in Germany. Z RHEUMATOL -: -, doi: 10.1007/s00393-018-0552-0
  12. Lipphardt M, Dihazi H, Müller GA, Goligorsky MS (2018) Fibrogenic Secretome of Sirtuin 1-Deficient Endothelial Cells: Wnt, Notch and Glycocalyx Rheostat. FRONT PHYSIOL 9: 1325, doi: 10.3389/fphys.2018.01325
  13. Lüders S, Schrader B, Bäsecke J, Haller H, Elsässer A, Koziolek M, Schrader J (2018) [ELITE study - Nutrition, lifestyle and individual information for the prevention of stroke, dementia and heart attack - Study design and cardiovascular status]. DEUT MED WOCHENSCHR -: -, doi: 10.1055/a-0714-3835
  14. Missbach-Guentner J, Pinkert-Leetsch D, Dullin C, Ufartes R, Hornung D, Tampe B, Zeisberg M, Alves F (2018) 3D virtual histology of murine kidneys -high resolution visualization of pathological alterations by micro computed tomography. SCI REP-UK 8(1): 1407, doi: 10.1038/s41598-018-19773-5
  15. Patschan D, Sugiarto N, Henze E, Mößner R, Mohr J, Müller GA, Patschan S (2018) Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis. EUR J MED RES 23(1): 56, doi: 10.1186/s40001-018-0352-7
  16. Patschan D, Müller GA (2018) [Acute Kidney Injury, AKI - Update 2018]. DEUT MED WOCHENSCHR 143(15): 1094-1096, doi: 10.1055/a-0523-4571
  17. Plüß M, Zeisberg M, Müller GA, Vasko R, Korsten P (2018) Therapeutic response to glucocorticoids, anticoagulation and plasma exchange in a patient with primary antiphospholipid syndrome presenting with purpura fulminans. LUPUS 27(13): 2170-2173, doi: 10.1177/0961203318804884
  18. Rauen T, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J (2018) Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy. J AM SOC NEPHROL 29(1): 317-325, doi: 10.1681/ASN.2017060713
  19. Savige J, Ariani F, Mari F, Bruttini M, Renieri A, Gross O, Deltas C, Flinter F, Ding J, Gale DP, Nagel M, Yau M, Shagam L, Torra R, Ars E, Hoefele J, Garosi G, Storey H (2018) Expert consensus guidelines for the genetic diagnosis of Alport syndrome. PEDIATR NEPHROL -: -, doi: 10.1007/s00467-018-3985-4
  20. Schmalz G, Dietl M, Vasko R, Müller GA, Rothermund L, Keller F, Ziebolz D, Rasche FM (2018) Dialysis vintage time has the strongest correlation to psychosocial pattern of oral health-related quality of life - a multicentre cross-sectional study. MED ORAL PATOL ORAL 23(6): e698-e706, doi: 10.4317/medoral.22624
  21. Schmalz G, Douglas D, Douglas D, Patschan S, Patschan D, Müller GA, Haak R, Schmickler J, Ziebolz D (2018) Oral health-related quality of life is associated with disease specific parameters in patients with ankylosing spondylitis. CLIN ORAL INVEST 22(8): 2889-2896, doi: 10.1007/s00784-018-2375-4
  22. Schrader B, Lüders S, Koziolek M, Haller H, Schrader J (2018) [New American Guidelines on Hypertension: New Consequences for German Patients?]. DEUT MED WOCHENSCHR 143(12): 907-911, doi: 10.1055/a-0593-0310
  23. Schwarze K, Kribben A, Ritter O, Müller GA, Patschan D (2018) Autophagy activation in circulating proangiogenic cells aggravates AKI in type I diabetes mellitus. AM J PHYSIOL-RENAL 315(4): F1139-F1148, doi: 10.1152/ajprenal.00502.2017
  24. Singh S, Lämmle S, Giese H, Kämmerer S, Meyer-Roxlau S, Alfar EA, Dihazi H, Guan K, El-Armouche A, Richter F (2018) The reduced activity of PP-1α under redox stress condition is a consequence of GSH-mediated transient disulfide formation. SCI REP-UK 8(1): 17711, doi: 10.1038/s41598-018-36267-6
  25. Tampe B, Zeisberg M (2018) Chromatin dynamics at the core of kidney fibrosis. MATRIX BIOL 68-69: 194-229, doi: 10.1016/j.matbio.2018.02.015
  26. Tampe B, Tampe D, Nyamsuren G, Klöpper F, Rapp G, Kauffels A, Lorf T, Zeisberg EM, Müller GA, Kalluri R, Hakroush S, Zeisberg M (2018) Pharmacological induction of hypoxia-inducible transcription factor ARNT attenuates chronic kidney failure. J CLIN INVEST 128(7): 3053-3070, doi: 10.1172/JCI89632
  27. Tichelbäcker T, Herath J, Tampe B, Korsten P (2018) Hemodiafiltration Treatment for Severe Valproic Acid Intoxication: Case Report and Updated Systematic Literature Review. Front Med (Lausanne) 5: 224, doi: 10.3389/fmed.2018.00224
  28. Vasko R, Müller GA (2018) A 27-Year-Old Man With Abruptly Occurring Chest Pain on Swallowing. DTSCH ARZTEBL INT 115(39): 652, doi: 10.3238/arztebl.2018.0652
  29. Wallbach M, Koziolek MJ (2018) [Therapy-resistant and therapy-refractory arterial hypertension]. INTERNIST 59(6): 567-579, doi: 10.1007/s00108-018-0430-5
  30. Wallbach M, Koziolek MJ, Wachter R (2018) [Baroreflex activation therapy: Indication and evidence in resistant hypertension and heart failure]. INTERNIST 59(10): 1011-1020, doi: 10.1007/s00108-018-0488-0
  31. Wallbach M, Böhning E, Lehnig LY, Schroer C, Müller GA, Wachter R, Lüders S, Zenker D, Koziolek MJ (2018) Safety profile of baroreflex activation therapy (NEO) in patients with resistant hypertension. J HYPERTENS 36(8): 1762-1769, doi: 10.1097/HJH.0000000000001753
  32. Wallbach M, Zürbig P, Dihazi H, Müller GA, Wachter R, Beige J, Koziolek MJ, Mischak H (2018) Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension. J CLIN HYPERTENS 20(10): 1519-1526, doi: 10.1111/jch.13365
  33. Xu X, Tan X, Tampe B, Wilhelmi T, Hulshoff MS, Saito S, Moser T, Kalluri R, Hasenfuss G, Zeisberg EM, Zeisberg M (2018) High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis. NAT COMMUN 9(1): 3509, doi: 10.1038/s41467-018-05766-5
  34. Zeisberg M, Koziolek MJ (2018) [Cardio-renal axis: Relationship of heart failure and renal insufficiency as comorbidities]. INTERNIST 59(5): 420-427, doi: 10.1007/s00108-018-0410-9
  35. Zhang X, Sun D, Song JW, Zullo J, Lipphardt M, Coneh-Gould L, Goligorsky MS (2018) Endothelial cell dysfunction and glycocalyx - A vicious circle. MATRIX BIOL 71-72: 421-431, doi: 10.1016/j.matbio.2018.01.026
  36. Ziebolz D, Douglas D, Douglas D, Schmickler J, Patschan D, Müller GA, Haak R, Schmidt J, Schmalz G, Patschan S (2018) Periodontal condition is associated with disease duration and motoric disabilities in patients with ankylosing spondylitis: results of a cross-sectional study. RHEUMATOL INT 38(5): 855-863, doi: 10.1007/s00296-018-4012-6
  37. Ziebolz D, Rupprecht A, Schmickler J, Bothmann L, Krämer J, Patschan D, Müller GA, Mausberg RF, Schmidt J, Schmalz G, Patschan S (2018) Association of different immunosuppressive medications with periodontal condition in patients with rheumatoid arthritis: Results from a cross-sectional study. J PERIODONTOL 89(11): 1310-1317, doi: 10.1002/JPER.17-0616

2017

  1. Andersen K, Kesper MS, Marschner JA, Konrad L, Ryu M, Kumar Vr S, Kulkarni OP, Mulay SR, Romoli S, Demleitner J, Schiller P, Dietrich A, Müller S, Gross O, Ruscheweyh HJ, Huson DH, Stecher B, Anders HJ (2017) Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation. J AM SOC NEPHROL 28(1): 76-83, doi: 10.1681/ASN.2015111285
  2. Beige J, Jentzsch T, Wendt R, Hennig G, Koziolek M, Wallbach M (2017) Blood pressure after blinded, randomized withdrawal, and resumption of baroreceptor-activating therapy. J HYPERTENS 35(7): 1496-1501, doi: 10.1097/HJH.0000000000001339
  3. Bergner R, Korsten P (2017) [Sarcoidosis as a systemic disease]. Z RHEUMATOL 76(5): 380-381, doi: 10.1007/s00393-017-0302-8
  4. Bramlage CP, Froelich B, Wallbach M, Minguet J, Grupp C, Deutsch C, Bramlage P, Müller GA, Koziolek M (2017) Urinary free light chains may help to identify infection in patients with elevated systemic inflammation due to rheumatic disease. RHEUMATOL INT 37(4): 599-605, doi: 10.1007/s00296-017-3666-9
  5. Bramlage CP, Kröplin J, Wallbach M, Minguet J, Smith KH, Lüders S, Schrader J, Patschan S, Gross O, Deutsch C, Bramlage P, Müller GA, Koziolek M (2017) Management of cardiovascular risk factors in patients with ANCA-associated vasculitis. J EVAL CLIN PRACT 23(4): 747-754, doi: 10.1111/jep.12709
  6. Bramlage CP, Wallbach M, Ellenberger D, Deutsch C, Minguet J, Smith KH, Stock J, Goninski A, Bramlage P, Koziolek M, Mueller GA (2017) Variables to Predict Nephrological Disease in General, and Glomerulonephritis in Particular, in Patients With Microhematuria. J Clin Med Res 9(7): 560-566, doi: 10.14740/jocmr2993w
  7. Groß O (2017) Alport Syndrom: Neue Medikamente am Horizont und Leitlinien zur Diagnose und Therapie. Nieren- und Hochdruckkrankheiten 46(3): 129-134
  8. Groß O (2017) Diagnostik und Therapie der chronischen Nierenerkrankung. Uro-News 21(10): 48-51, doi: 10.1007/s00092-017-1627-y
  9. Groß O (2017) Leben mit Alport-Syndrom. Der Nephrologe 12(4): 257-263, doi: doi.org/10.1007/s11560-017-0158-6
  10. Kirchner A, Jäger J, Krohn-Grimberghe B, Patschan S, Kottmann T, Schmalz G, Mausberg RF, Haak R, Ziebolz D (2017) Active matrix metalloproteinase-8 and periodontal bacteria depending on periodontal status in patients with rheumatoid arthritis. J PERIODONTAL RES 52(4): 745-754, doi: 10.1111/jre.12443
  11. Korsten P, Chehab G (2017) [Musculoskeletal manifestations of sarcoidosis]. Z RHEUMATOL 76(5): 408-414, doi: 10.1007/s00393-017-0313-5
  12. Korsten P, Vasko R (2017) [77-Year-Old Male Patient with Joint Pain after a Tick Bite]. DEUT MED WOCHENSCHR 142(5): 325-327, doi: 10.1055/s-0043-100033
  13. Korsten P, Bahlmann D, Patschan SA (2017) Rapid healing of peripheral ulcerative keratitis in rheumatoid arthritis with prednisone, methotrexate and adalimumab combination therapy. RHEUMATOLOGY 56(7): 1094, doi: 10.1093/rheumatology/kex007
  14. Korsten P, Niewold TB, Zeisberg M, Utset TO, Cho D, Zachary LS, Sweiss NJ, Volkov S (2017) Increased Whole Blood Viscosity Is Associated with the Presence of Digital Ulcers in Systemic Sclerosis: Results from a Cross-Sectional Pilot Study. Autoimmune Dis 2017: 3529214, doi: 10.1155/2017/3529214
  15. Koziolek M, Beige J, Wallbach M, Zenker D, Henning G, Halbach M, Mader N, Mahfoud F, Schlieper G, Schwenger V, Hausberg M, Börgel J, Lodde M, van der Giet M, Müller-Ehmsen J, Passauer J, Parmentier S, Lüders S, Krämer BK, Büttner S, Limbourg F, Jordan J, Vonend O, Predel HG, Reuter H (2017) [Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017]. INTERNIST 58(10): 1114-1123, doi: 10.1007/s00108-017-0308-y
  16. Lipphardt M, Song JW, Matsumoto K, Dadafarin S, Dihazi H, Müller G, Goligorsky MS (2017) The third path of tubulointerstitial fibrosis: aberrant endothelial secretome. KIDNEY INT 92(3): 558-568, doi: 10.1016/j.kint.2017.02.033
  17. Lipphardt M, Song JW, Ratliff BB, Dihazi H, Müller GA, Goligorsky MS (2017) ENDOTHELIAL DYSFUNCTION IS A SUPER-INDUCER OF SYNDECAN 4: fibrogenic role of its ectodomain. AM J PHYSIOL-HEART C -: ajpheart.00548.2017, doi: 10.1152/ajpheart.00548.2017
  18. Mühlberg S, Jäger J, Krohn-Grimberghe B, Patschan S, Mausberg RF, Schmalz G, Haak R, Ziebolz D (2017) Oral health-related quality of life depending on oral health in patients with rheumatoid arthritis. CLIN ORAL INVEST 21(9): 2661-2670, doi: 10.1007/s00784-017-2068-4
  19. Patschan D, Schwarze K, Tampe B, Zeisberg M, Patschan S, Müller GA (2017) Endothelial Colony Forming Cells (ECFCs) in murine AKI - implications for future cell-based therapies. BMC NEPHROL 18(1): 53, doi: 10.1186/s12882-017-0471-3
  20.   Patschan D, Müller GA (2017) [Diagnostics and Non-Dialytic Management of AKI - Update]. DEUT MED WOCHENSCHR 142(11): 821-824, doi: 10.1055/s-0043-105722
  21. Schmalz G, Schiffers N, Schwabe S, Vasko R, Müller GA, Haak R, Mausberg RF, Ziebolz D (2017) Dental and periodontal health, and microbiological and salivary conditions in patients with or without diabetes undergoing haemodialysis. INT DENT J 67(3): 186-193, doi: 10.1111/idj.12282
  22. Song JW, Zullo J, Lipphardt M, Dragovich M, Zhang FX, Fu B, Goligorsky MS (2017) Endothelial glycocalyx-the battleground for complications of sepsis and kidney injury. NEPHROL DIAL TRANSPL -: -, doi: 10.1093/ndt/gfx076
  23. Stock J, Kuenanz J, Glonke N, Sonntag J, Frese J, Tönshoff B, Höcker B, Hoppe B, Feldkötter M, Pape L, Lerch C, Wygoda S, Weber M, Müller GA, Gross O (2017) Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations. PEDIATR NEPHROL 32(1): 131-137, doi: 10.1007/s00467-016-3452-z
  24. Tampe B, Steinle U, Tampe D, Carstens JL, Korsten P, Zeisberg EM, Müller GA, Kalluri R, Zeisberg M (2017) Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression. KIDNEY INT 91(1): 157-176, doi: 10.1016/j.kint.2016.07.042
  25. Wallbach M, Dihazi H, Koziolek MJ, Müller GA (2017) Differenzialdiagnosen bei Proteinurie. Nieren- und Hochdruckkrankheiten 9: 397-401
  26. Wallbach M, Koziolek MJ (2017) Baroreceptors in the carotid and hypertension-systematic review and meta-analysis of the effects of baroreflex activation therapy on blood pressure. NEPHROL DIAL TRANSPL -: -, doi: 10.1093/ndt/gfx279
  27. Zafar S, Behrens C, Dihazi H, Schmitz M, Zerr I, Schulz-Schaeffer WJ, Ramljak S, Asif AR (2017) Cellular prion protein mediates early apoptotic proteome alternation and phospho-modification in human neuroblastoma cells. CELL DEATH DIS 8(1): e2557, doi: 10.1038/cddis.2016.384

2016

  1. Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, Qaqish N, Saketkoo LA, Baughman RP, Sweiss NJ (2016) Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag 12: 1623-1634, doi: 10.2147/TCRM.S74476
  2. Bramlage CP, Nasiri-Sarvi M, Minguet J, Bramlage P, Müller GA (2016) Characterization and history of arterial hypertension leading to inpatient treatment. BMC Res Notes 9(1): 480, doi: 10.1186/s13104-016-2285-y
  3. Bramlage CP, Froelich B, Wallbach M, Minguet J, Grupp C, Deutsch C, Bramlage P, Koziolek M, Müller GA (2016) The significance and predictive value of free light chains in the urine of patients with chronic inflammatory rheumatic disease. CLIN RHEUMATOL 35(12): 2939-2946, doi: 10.1007/s10067-016-3437-0
  4. Dihazi H, Koziolek MJ, Datta RR, Wallbach M, Jung K, Heise D, Dihazi GH, Markovic I, Asif AR, Müller GA (2016) FABP1 and FABP3 Have High Predictive Values for Renal Replacement Therapy in Patients with Acute Kidney Injury. BLOOD PURIFICAT 42(3): 202-13, doi: 10.1159/000447115
  5. Eltoweissy M, Dihazi GH, Müller GA, Asif AR, Dihazi H (2016) Protein DJ-1 and its anti-oxidative stress function play an important role in renal cell mediated response to profibrotic agents. MOL BIOSYST 12(6): 1842-59, doi: 10.1039/c5mb00887e
  6. Gross O, Kashtan CE, Rheault MN, Flinter F, Savige J, Miner JH, Torra R, Ars E, Deltas C, Savva I, Perin L, Renieri A, Ariani F, Mari F, Baigent C, Judge P, Knebelman B, Heidet L, Lagas S, Blatt D, Ding J, Zhang Y, Gale DP, Prunotto M, Xue Y, Schachter AD, Morton LCG, Blem J, Huang M, Liu S, Vallee S, Renault D, Schifter J, Skelding J, Gear S, Friede T, Turner AN, Lennon R (2016) Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome. NEPHROL DIAL TRANSPL -: -, doi: 10.1093/ndt/gfw095
  7. Klionsky DJ, Abdelmohsen K, Abe A, ET AL, ET AL, ET AL, ET AL (2016) Guidelines for use and interpretation of assays for monitoring autophagy (3rd Edition). AUTOPHAGY 12(1): 1-222, doi: 10.1080/15548627.2015.1100356
  8. Korsten P, Blaschke S (2016) A 28-Year-Old Man with Impaired Vision. DTSCH ARZTEBL INT 113(39): 662, doi: 10.3238/arztebl.2016.0662
  9. Korsten P, Blaschke S (2016) A 76-Year-Old Man with COPD and Acute Dyspnea. DTSCH ARZTEBL INT 113(48): 824, doi: 10.3238/arztebl.2016.0824
  10. Korsten P, Blaschke S (2016) Left Flank Pain in a 73-Year-Old Man. DTSCH ARZTEBL INT 113(41): 691, doi: 10.3238/arztebl.2016.0691
  11. Korsten P, Moritz Klemm PC, Vasko R (2016) [54-year old man with pain in hand and finger joints]. DEUT MED WOCHENSCHR 141(21): 1529, doi: 10.1055/s-0042-115053
  12. Korsten P, Patschan D, Henze E, Niewold TB, Müller GA, Patschan S (2016) Dynamics of pulse wave velocity and vascular augmentation index in association with endothelial progenitor cells in SLE. Lupus Sci Med 3(1): e000185, doi: 10.1136/lupus-2016-000185
  13. Korsten P, Strohmayer K, Baughman RP, Sweiss NJ (2016) Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach. Clin Pulm Med 23(2): 67-75, doi: 10.1097/CPM.0000000000000136
  14. Lenz C, Dihazi H (2016) Introduction to Proteomics Technologies. Methods Mol Biol 1362: 3-27, doi: 10.1007/978-1-4939-3106-4_1
  15. Liu X, Qi J, Xu X, Zeisberg M, Guan K, Zeisberg EM (2016) Differentiation of functional endothelial cells from human induced pluripotent stem cells: A novel, highly efficient and cost effective method. DIFFERENTIATION 92(4): 225-236, doi: 10.1016/j.diff.2016.05.004
  16. Lovisa S, Zeisberg M, Kalluri R (2016) Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis. TRENDS ENDOCRIN MET 27(10): 681-695, doi: 10.1016/j.tem.2016.06.004
  17. Maisel AS, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müller GA, Birkhahn R, Clopton P, Taub P, Vilke GM, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Murray PT (2016) Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study. J AM COLL CARDIOL 68(13): 1420-31, doi: 10.1016/j.jacc.2016.06.055
  18. Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sørensen SS, Hadaya K, Oberbauer R, Dudley C, De Fijter JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Pérez-Sáez MJ, Mühlfeld A, Orlando G, Clemente K, Lai Q, Pisani F, Kandus A, Baas M, Bemelman F, Ponikvar JB, Mazouz H, Stratta P, Subra JF, Villemain F, Hoitsma A, Braun L, Cantarell MC, Colak H, Courtney A, Frasca GM, Howse M, Naesens M, Reischig T, Serón D, Seyahi N, Tugmen C, Alonso Hernandez A, Beňa L, Biancone L, Cuna V, Díaz-Corte C, Dufay A, Gaasbeek A, Garnier A, Gatault P, Gentil Govantes MA, Glowacki F, Gross O, Hurault de Ligny B, Huynh-Do U, Janbon B, Jiménez Del Cerro LA, Keller F, La Manna G, Lauzurica R, Le Monies De Sagazan H, Thaiss F, Legendre C, Martin S, Moal MC, Noël C, Pillebout E, Piredda GB, Puga AR, Sulowicz W, Tuglular S, Prokopova M, Chesneau M, Le Moine A, Guérif P, Soulillou JP, Abramowicz M, Giral M, Racapé J, Maggiore U, Brouard S, Abramowicz D (2016) The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients. NEPHROL DIAL TRANSPL 31(6): 1002-13, doi: 10.1093/ndt/gfv437
  19. Metz I, Beißbarth T, Ellenberger D, Pache F, Stork L, Ringelstein M, Aktas O, Jarius S, Wildemann B, Dihazi H, Friede T, Brück W, Ruprecht K, Paul F (2016) Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis. NEUROL-NEUROIMMUNOL 3(2): e204, doi: 10.1212/NXI.0000000000000204
  20. Nagel M, Gross O (2016) Das Alport-Syndrom als wichtige Differentialdiagnose einer Hämaturie. Nieren- und Hochdruckkrankheiten. Nieren- und Hochdruckkrankheiten 7(45): 267-272
  21. Patschan D, Müller GA (2016) Acute Kidney Injury in Diabetes Mellitus. Int J Nephrol 2016: 6232909, doi: 10.1155/2016/6232909
  22. Patschan D, Kribben A, Müller GA (2016) Postischemic microvasculopathy and endothelial progenitor cell-based therapy in ischemic AKI: update and perspectives. AM J PHYSIOL-RENAL 311(2): F382-94, doi: 10.1152/ajprenal.00232.2016
  23. Patschan D, Schwarze K, Henze E, Patschan S, Müller GA (2016) Endothelial-to-Mesenchymal Transition and endothelial cilia in EPC-mediated postischemic kidney protection. AM J PHYSIOL-RENAL -: ajprenal.00306.2015, doi: 10.1152/ajprenal.00306.2015
  24. Patschan S, Tampe D, Müller C, Seitz C, Herink C, Müller GA, Zeisberg E, Zeisberg M, Henze E, Patschan D (2016) Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation. BMC MUSCULOSKEL DIS 17(1): 339, doi: 10.1186/s12891-016-1197-2
  25. Raupach T, Andresen JC, Meyer K, Strobel L, Koziolek M, Jung W, Brown J, Anders S (2016) Test-enhanced learning of clinical reasoning: a crossover randomised trial. MED EDUC 50(7): 711-20, doi: 10.1111/medu.13069
  26. Schäfer EJ, Jung W, Korsten P (2016) Combination Immunosuppressive Therapy Including Rituximab for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adult-Onset Still's Disease. Case Rep Rheumatol 2016: 8605274, doi: 10.1155/2016/8605274
  27. Schmalz G, Kollmar O, Vasko R, Müller GA, Haak R, Ziebolz D (2016) Oral health-related quality of life in patients on chronic haemodialysis and after kidney transplantation. ORAL DIS 22(7): 665-72, doi: 10.1111/odi.12519
  28. Schmalz G, Kauffels A, Kollmar O, Slotta JE, Vasko R, Müller GA, Haak R, Ziebolz D (2016) Oral behavior, dental, periodontal and microbiological findings in patients undergoing hemodialysis and after kidney transplantation. BMC ORAL HEALTH 16(1): 72, doi: 10.1186/s12903-016-0274-0
  29. Schmickler J, Rupprecht A, Patschan S, Patschan D, Müller GA, Haak R, Mausberg RF, Schmalz G, Kottmann T, Ziebolz D (2016) Cross-sectional Evaluation of Periodontal Status, Microbiological and Rheumatoid Parameters in a large Cohort of Patients With Rheumatoid Arthritis. J PERIODONTOL November: 1-17, doi: 10.1902/jop.2016.160355
  30. Schminke B, Frese J, Bode C, Goldring MB, Miosge N (2016) Laminins and Nidogens in the Pericellular Matrix of Chondrocytes: Their Role in Osteoarthritis and Chondrogenic Differentiation. AM J PATHOL 186(2): 410-8, doi: 10.1016/j.ajpath.2015.10.014
  31. Tan X, Xu X, Zeisberg EM, Zeisberg M (2016) High inorganic phosphate causes DNMT1 phosphorylation and subsequent fibrotic fibroblast activation. BIOCHEM BIOPH RES CO 472(3): 459-64, doi: 10.1016/j.bbrc.2016.01.077
  32. Tan X, Xu X, Zeisberg M, Zeisberg EM (2016) DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition. PLOS ONE 11(1): e0147816, doi: 10.1371/journal.pone.0147816
  33. Trivedi R, Dihazi GH, Eltoweissy M, Mishra DP, Mueller GA, Dihazi H (2016) The antioxidant protein PARK7 plays an important role in cell resistance to Cisplatin-induced apoptosis in case of clear cell renal cell carcinoma. EUR J PHARMACOL 784: 99-110, doi: 10.1016/j.ejphar.2016.04.014
  34. Trivedi R, Müller GA, Rathore MS, Mishra DP, Dihazi H (2016) Anti-Leukemic Activity of Shikonin: Role of ERP57 in Shikonin Induced Apoptosis in Acute Myeloid Leukemia. Cell Physiol Biochem 39(2): 604-16, doi: 10.1159/000445652
  35. Vasko R, Blaschke S, Streich JH, Müller GA, Korsten P, Dihazi H (2016) Comparative Serum Proteomic Analysis of Differentially Regulated Proteins in Patients with Rheumatoid Arthritis and Healthy Volunteers. Journal of Arthritis 5(3): -, doi: 10.4172/2167-7921.1000201
  36. Vasko R (2016) Peroxisomes and Kidney Injury. ANTIOXID REDOX SIGN 25(4): 217-31, doi: 10.1089/ars.2016.6666
  37. Vasko R, Streich JH, Blaschke S, Müller GA, Mai B, Kostrzewa M, Sparbier K, Korsten P, Bohr S, Dihazi H (2016) Vimentin fragments are potential markers of rheumatoid synovial fibroblasts. CLIN EXP RHEUMATOL 34(3): 513-20
  38. Wallbach M, Koziolek MJ (2016) Barorezeptoraktivierungstherapie: mehr als Blutdrucksenkung? Nieren- und Hochdruckkrankheiten 45: 304-309
  39. Wallbach M, Vasko R, Hoffmann S, Niewold TB, Müller GA, Korsten P (2016) Elevated procalcitonin levels in a severe lupus flare without infection. LUPUS 25(14): 1625-1626, doi: 10.1177/0961203316651746
  40. Wallbach M, Duque Escobar J, Babaeikelishomi R, Stahnke MJ, Blume R, Schröder S, Kruegel J, Maedler K, Kluth O, Kehlenbach RH, Miosge N, Oetjen E (2016) Distinct functions of the dual leucine zipper kinase depending on its subcellular localization. CELL SIGNAL 28(4): 272-83, doi: 10.1016/j.cellsig.2016.01.002
  41. Wallbach M, Halbach M, Reuter H, Passauer J, Lüders S, Böhning E, Zenker D, Müller GA, Wachter R, Koziolek MJ (2016) Baroreflex activation therapy in patients with prior renal denervation. J HYPERTENS 34(8): 1630-8, doi: 10.1097/HJH.0000000000000949
  42. Wallbach M, Lehnig LY, Schroer C, Lüders S, Böhning E, Müller GA, Wachter R, Koziolek MJ (2016) Effects of Baroreflex Activation Therapy on Ambulatory Blood Pressure in Patients With Resistant Hypertension. HYPERTENSION 67(4): 701-9, doi: 10.1161/HYPERTENSIONAHA.115.06717
  43. Xu X, Tan X, Hulshoff MS, Wilhelmi T, Zeisberg M, Zeisberg EM (2016) Hypoxia-induced endothelial-mesenchymal transition is associated with RASAL1 promoter hypermethylation in human coronary endothelial cells. FEBS LETT 590(8): 1222-33, doi: 10.1002/1873-3468.12158

Buchbeiträge

  1. Bernateck M, Heppner C, Korsten P, Siggelkow H (2019) Gelenk- und Muskelschmerzen. In: Baron R, Koppert W, Strumpf M, Willweber-Strumpf A (Hg.) Praktische Schmerzmedizin. Springer, , 347-373
  2. Gross O (2019) Alport Syndrom. In: Akademie Niere (Hg.) XIV. Intensivkurs Nieren- und Hochdruckkrankheiten der Akademie Niere. Pabst Science Publishers, , 99-111
  3. Gross O (2019) Hereditäre Onychoosteodysplasie - Nagel-Patella-Syndrom. In: Alscher (Hg.) Erkrankungen mit Befall der Glomerula. Georg Thieme Verlag, , 376-378
  4. Gross O (2019) Hereditäre Typ-IV-Kollagen-Erkrankungen: Alport-Syndrom und "Thin Basement Membrane Nephropathy". In: Alscher (Hg.) Erkrankungen mit Befall der Glomerula. Georg Thieme Verlag, , 368-376
  5. Korsten P (2019) Granulomatöse interstitielle Nephritis. In: Alscher M (Hg.) Referenz Nephrologie. Georg Thieme Verlag, , 370-373
  6. Korsten P (2019) Interstitielle Nephritis bei Sarkoidose. In: Alscher M (Hg.) Referenz Nephrologie. Georg Thieme Verlag, , 366-369
  7. Gross O (2018) Alport Syndrom. In: Akademie Niere (Hg.) XIII.Intensivkurs Nieren-und Hochdruckkrankheiten der Akademie Niere. Pabst Science Publishers, , 97-109
  8. Gross O, Wallbach M, Müller GA (2018) Interstitielle Nephritis. In: Brunkhorst/Schölmerich (Hg.) Differentialdiagnostik und Differentialtherapie. Elsevier, München, 272-273
  9. Gross O, Wallbach M, Müller GA (2018) Zystennieren. In: Brunkhorst/Schölmerich (Hg.) Differentialdiagnostik und Differentialtherapie. Elsevier, München, 446-447
  10. Groß O (2017) Alport Syndrom. In: Pabst Science Publishers (Hg.) XII. Intensivkurs Nieren- und Hochdruckkrankheiten der Akademie Niere. Pabst Science Publishers, , 86-98
  11. Gross O, Bergmann C, Hildebrandt F, Huber T, Zerres K, Zenker M (2017) Hereditäre Nephropathien. In: Verlag Urban & Fischer bei Elsevier (Hg.) Rationelle Diagnostik und Therapie in der Inneren Medizin, Leitlinien. Urban & Fischer Verlag, München, Jena., 1-40
  12. Gross O (2016) Alport-Syndrom. In: Akademie Niere (Hg.) Lehrbuch für Nieren- und Hochdruckkrankheiten. Pabst Science Publishers, Lengerich, 84-93
  13. Gross O (2016) Hereditäre Nephropathien. In: Keller/ Ketteler/ Schindler/ Heemann und Wolf (Hg.) Manuale Nephrologicum. Dustri Verlag, , 1-10
  14. Sweiss NJ, Korsten P, Baughman RP (2016) Sarcoidosis. In: Elsevier (Hg.) KELLEY AND FIRESTEIN’S TEXTBOOK OF RHEUMATOLOGY, TENTH EDITION. Elsevier, Oxford, 1983-1996

Habilitationen und Dissertationen

Habilitationen

  1. Vasko R (2017) Mechanisms of Endothelial Dysfunction in Renal Injury. Habilitation Universität Göttingen.
  2. Wallbach M (2017) Organoprotektive Effekte der Barorezeptoraktivierungstherapie. Habilitation Universität Göttingen.

Medizinische Dissertationen

  1. Künanz J, Dr. med. (2020) Der langfristige Effekt einer RAAS-Blockade auf den Krankheitsverlauf bei heterozygoten Mutationsträgern des Alport-Syndroms - Eine prospektive Vier-Jahres-Auswertung des Europäischen Alport-Registers. Dissertation Universität Göttingen.
  2. Valk JJ, Dr. med. (2020) Komplementinhibition mittels Eculizumab verstärkt den nephroprotektiven Effekt von ACE-Inhibitoren in einem COL4A3-Knockout-Mausmodell für das Alport-Syndrom. Dissertation Universität Göttingen.
  3. Bonss MR, Dr. med. (2019) Analyse organoprotektiver Effekte der renalen Denervation zur Behandlung therapierefraktärer arterieller Hypertonie. Dissertation Universität Göttingen.
  4. Hesse F, Dr. med. (2019) Serelaxin-vermittelte Inhibition von Fibroblastenaktivierung bei renaler Fibrogenese. Dissertation Universität Göttingen.
  5. Katzendorn O, Dr. med. (2019) Die Rolle der Proteindisulfidisomerase ERp57 in der Chemoresistenz des Nierenzellkarzinoms. Dissertation Universität Göttingen.
  6. Schierke KA, Dr. med. (2019) Effekte der Barorezeptoraktivierungstherapie auf Marker des Endoplasmatischen Retikulum Stresses. Dissertation Universität Göttingen.
  7. Steinle U, Dr. med. (2019) Epigenetische Therapie mit niedrig dosiertem Hydralazin verhindert die Progression vom akuten ins chronische Nierenversagen im Mausmodell. Dissertation Universität Göttingen.
  8. Vogt ME, Dr. med. (2019) Die Rolle der endothelialen Progenitorzellen bei Patienten mit axialer Spondylarthropathie. Dissertation Universität Göttingen.
  9. Fetsch gKT, Dr. med. (2018) Analysis of Lymphocytes with T regulatory Phenotype in Kidney Allografts of Saint-Petersburg. Dissertation Universität Göttingen.
  10. Glonke N, Dr. med. (2018) Prospektive Verlaufsstudie über die Auswirkung der RAAS-Blockade bei Trägern des Alport-Syndroms. Dissertation Universität Göttingen.
  11. Hoffmann J, Dr. med. (2018) Untersuchung von Biomarkern bei Patienten mit ANCA-assoziierter Vaskulitis. Dissertation Universität Göttingen.
  12. Lemmer gBD, Dr. med. (2018) Vaskuläres Regenerationspotential im Muskel und endotheliale Vorläuferzellen im Blut bei Patienten mit Myositis. Dissertation Universität Göttingen.
  13. Delistefani F, Dr. med. (2017) Der CRP-Wert zum Zeitpunkt der Dialysekatheter-Implantation als Risikofaktor für die Entwicklung einer Katheter-assoziierten Komplikation. Dissertation Universität Göttingen.
  14. Lehnig L, Dr. med. (2017) Analyse organoprotektiver Effekte durch eine Barorezeptorstimulationstherapie zur Behandlung der Therapie-refraktären arteriellen Hypertonie. Dissertation Universität Göttingen.
  15. Mavropoulou E, Dr. med. (2017) Point of care-Ultraschall versus Röntgen-Thorax zur Lagekontrolle zentralvenöser Katheter. Dissertation Universität Göttingen.
  16. Mertens A, Dr. med. (2017) Behandlungserfolg und Prognose des akuten Nierenversagens bei Patienten mit Sepsis und onkologischen Erkrankungen. Dissertation Universität Göttingen.
  17. Mühlhausen J, Dr. med. (2017) Immunadsorption und Plasmapherese in der Behandlung von Multipler Sklerose und Neuromyelitis Optica. Dissertation Universität Göttingen.
  18. Scheidmann R, Dr. med. (2017) Die Effekte von PPARalpha auf die therapeutische Effektivität von eEOCs beim ischämisch bedingten akuten Nierenversagen von eEOC-behandelten C57BI/6N-Mäusen. Dissertation Universität Göttingen.
  19. Barclay-Steuart AJ, Dr. med. (2016) Evaluation der Prognose des akuten Nierenversagens nach kardiopulmonaler Reanimation und milder therapeutischer Hypothermie. Dissertation Universität Göttingen.
  20. Ciner A, Dr. med. (2016) Nierenschützende Wirkung von Calcitriol additiv zu Ramipril auf die Nierenfibrose im Alport-Maus-Modell. Dissertation Universität Göttingen.
  21. Mendoza Schulz L, Dr. med. (2016) Gesundheitsbezogene Lebensqualität bei Tumorpatienten unter besonderer Berücksichtigung krebsassoziierter Fatigue - Analyse eines Kollektivs von 1800 Tumorpatienten in Deutschland. Dissertation Universität Göttingen.
  22. Prinz CS, Dr. med. (2016) Nidogen-2 in der Pathogenese Kollagen IV-assoziierter Nephropathien bei zusätzlicher Podocin-Mutation. Dissertation Universität Göttingen.

Zahnmedizinische Dissertationen

  1. Idrizi N, Dr. med. dent. (2017) Angiopoetin-1 im Kontext von EPC-vermittelter Nephroprotektion nach akuter renaler Ischämie. Dissertation Universität Göttingen.
  2. Klöpper F, Dr. med. dent. (2017) Die Rolle des FK506 bei der Expression des BMP-Rezeptors BMPR1A. Dissertation Universität Göttingen.
  3. Spieker C, Dr. med. dent. (2017) Die Bedeutung der glomerulären Basalmembrankomponente Nidogen-1 bei podozytären Erkrankungen der Niere. Dissertation Universität Göttingen.

Das könnte Sie auch interessieren

Folgen Sie uns